CIK: 1206872 - Address: C/O Gyre Therapeutics, Inc., 12770 High Bluff Drive, Suite 150, San Diego, CA 92130
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret111731-1-19-20-57-10
P%wins100100000033

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/1/24 18:00
6/28/24
GYREGyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsUsman NassimCADM.d246.93032D
7/1/24 18:00
6/28/24
GYREGyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsUsman NassimCADS.d-4112.000-3-602D
5/2/24 18:19
5/1/24
GYREGyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsUsman NassimCADM.d1396.930202D
5/2/24 18:19
5/1/24
GYREGyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsUsman NassimCADS.d-28314.130-20-902D
4/3/24 16:01
4/1/24
GYREGyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsUsman NassimCADM.d1396.930202D
4/3/24 16:01
4/1/24
GYREGyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsUsman NassimCADS.d-32316.150-20-902D
3/19/24 16:47
3/15/24
GYREGyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsUsman NassimCADM.d1396.930202D
3/19/24 16:47
3/15/24
GYREGyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsUsman NassimCADS.d-34517.260-20-902D
8/10/22 17:19
8/9/22
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOP20.4700031134D
2/16/22 20:13
2/9/22
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOP10.4600031231D
8/11/21 09:15
8/9/21
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOP33.6201328D
4/7/21 10:55
4/5/21
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOM.d234.63052327D
2/22/21 21:33
2/9/21
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOP34.8101322D
8/12/20 16:12
8/10/20
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOP34.8101321D
3/13/20 18:56
3/13/20
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOP163.91042421D
5/22/19 14:17
5/21/19
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOM.d204.63043916M
2/4/19 16:51
1/31/19
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOM.d274.630610811D
4/6/18 17:03
4/4/18
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOM.d04.630019D
12/18/15 17:43
12/17/15
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsUsman NassimCADOP,CEOP82.00043139I-3192-71-46-36-22-8731-1-19-20-57

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact